Kineta (KA) Delisting to OTC Sep 20, 2024 06:16AM
TuHURA Biosciences and Kintara Therapeutics (KTRA) Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer Aug 19, 2024 09:13AM
TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer Aug 19, 2024 09:00AM